Apellis Pharmaceuticals I... (APLS)
NASDAQ: APLS
· Real-Time Price · USD
27.62
1.04 (3.91%)
At close: Aug 14, 2025, 3:59 PM
27.00
-2.24%
Pre-market: Aug 15, 2025, 04:01 AM EDT
Apellis Pharmaceuticals Revenue
Apellis Pharmaceuticals reported an annual revenue of $781.37M, reflecting a 97.02% growth. For the quarter ending June 30, 2025, Apellis Pharmaceuticals generated $178.49M in revenue.
Revenue (ttm)
781.37M
Revenue Growth
97.02%
Price / Sales Ratio
5.06
Revenue / Employee
1.11M
Employees
705
Market Cap
3.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|